El programa de seguridad de los alimentos de la FDA se debe renovar, según un panel
MIÉRCOLES, 7 de diciembre de 2022 (HealthDay News) — El programa de alimentos de la Administración de Alimentos y Medicamentos (FDA) de EE. UU. está en una “agitación constante” y necesita un liderazgo más fuerte, señaló un panel el jueves.La Reagan-…
Learn MoreFDA OKs Bivalent COVID Boosters for Kids 6 Months and Older
THURSDAY, Dec. 8, 2022 (HealthDay News) — The updated bivalent COVID-19 boosters are now approved for use in children as young as 6 months of age, the U.S. Food and Drug Administration announced today.Children can receive either a Moderna or Pfizer-B…
Learn MoreCOVID-19 Vaccine Prevents Against Reinfection
WEDNESDAY, Dec. 7, 2022 (HealthDay News) — Completing a primary COVID-19 vaccination series is associated with significant protection against reinfection among previously infected individuals, according to a study published online Nov. 22 in PLOS Med…
Learn MoreFDA Food Safety Program Needs a Revamp: Panel
WEDNESDAY, Dec. 7, 2022 (HealthDay News) — The U.S. Food and Drug Administration foods program is in “constant turmoil” and needs stronger leadership, a panel said Thursday.The Reagan-Udall Foundation, a group with close ties to the FDA, released a 5…
Learn MorePaxlovid Soon Will Not Be Free for Americans
WEDNESDAY, Dec. 7, 2022 (HealthDay News) — The antiviral Paxlovid has kept patients from becoming severely ill and dying from COVID-19 since it became available — at no cost to them. But by the middle of next year, the U.S. government will stop subs…
Learn MoreAumentan los casos de gripe en EE. UU., e instan a los adultos mayores a vacunarse
MARTES, 6 de diciembre de 2022 (HealthDay News) — Los expertos les piden a los adultos mayores que se vacunen contra la gripe lo antes posible, mientras una temporada de gripe excepcionalmente desagradable se despliega por todo Estados Unidos.Ya se h…
Learn MorePaxlovid Soon Won’t Be Free for Americans
WEDNESDAY, Dec. 7, 2022 (HealthDay News) — The antiviral Paxlovid has kept people from getting really sick and dying from COVID-19 since it became available — at no cost to them. But by the middle of next year, the U.S. government will stop subsidiz…
Learn MoreSGLT-2i Use Before COVID-19 May Reduce Adverse Outcomes in Diabetes Patients
WEDNESDAY, Dec. 7, 2022 (HealthDay News) — For patients with diabetes subsequently diagnosed and hospitalized with COVID-19, use of a sodium-glucose cotransporter-2 inhibitor (SGLT-2i) before COVID-19 infection is associated with lower COVID-19-relat…
Learn MoreFDA’s Food Safety Program Needs a Revamp: Panel
WEDNESDAY, Dec. 7, 2022 (HealthDay News) – The U.S. Food and Drug Administration’s foods program is in “constant turmoil” and needs stronger leadership, a panel said Thursday. The Reagan-Udall Foundation, a group with close ties to the FDA, released a…
Learn MoreLas células T inmunitarias aún pueden luchar contra las variantes de la COVID, ¿pero por cuánto tiempo?
LUNES, 5 de diciembre de 2022 (HealthDay News) — Aunque las células T del sistema inmunitario de las personas todavía pueden atacar a las proteínas de pico del coronavirus de la COVID, su capacidad de hacerlo está menguando con el tiempo, informan un…
Learn More